A carregar...
FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019
This retrospective review assesses the frequency of surrogate measures used for the first time vs subsequent times in a cancer setting and the surrogate’s strength of correlation with patient-centered outcomes.
Na minha lista:
| Publicado no: | JAMA Intern Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7186918/ https://ncbi.nlm.nih.gov/pubmed/32338703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.1097 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|